OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

7th Emirates Oncology Society Annual Conference 2026 Set to Bring Together Oncology Experts in Dubai

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

10 Must-Read Posts In GU Oncology This Week

The Dangers We Fear and the Everyday Risks We Learn to Ignore

Targeted Therapy Resistance in NSCLC: Critical Next Steps

Oncology News, Insights, Stories by OncoDaily

President of Botswana Duma Boko
OncoDaily Magazine

The Hidden Gem in the Land of Gems: A Harvard-trained human rights lawyer is opening Botswana's doors to the biomedical industry — and the world should be paying attention.

BeOne Medicines and Revolution Medicines Partner on RAS(ON) Cancer Therapies
OncoIndustry

BeOne Medicines and Revolution Medicines Partner on RAS(ON) Cancer Therapies

ESO- OncoDaily
Not To Miss

ESO College Council Elections Announced for 2027–2028

Fabio Ynoe Moraes: Managing Brain-Only Progression in Extensive-Stage SCLC

Moffitt Cancer Center Celebrates the Opening of the Richard M. Schulze Family Foundation Proton Center

Louis van Gaal’s Remarkable Prostate Cancer Journey: Diagnosis, Treatment, and Recovery

Stephen Modise: Reliable Healthcare for Every Motswana Is Within Reach

1000 Voices for Cancer Equity National Listening Campaign

Monica Bertagnolli: Why We All Need to Care About What Happens to Dr. Tony Fauci

Gevorg Tamamyan: Registration Open for OncoDaily and PICI's IMMUNÕ 2026 Virtual Congress

Voices
Chris Boerner

Chris Boerner։ Bristol Myers Squibb Invests $2.3 Billion in New Houston Manufacturing Campus

Raul Mostoslavsky: Thrilled to Congratulate Tiziano Bernasocchi an Instructor in My Lab

Maziar Mike Doustdar: Novo Nordisk is Expanding its Collaboration With Amazon Web Services

Vivek Subbiah: Use of CtDNA May Help Select Best Treatment and Timing of Therapy

Yan Leyfman: Thank You to Zara Baloch for Her Great Coverage of the ICE-T Conference

Highlighting Innovation Across Oncology Research - MOASC

From Patient Advocacy to Lived Experience Advocacy

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The 2027 ASPHO Conference

American Society of Pediatric Hematology/Oncology (ASPHO)

11 May
ASPHO Conference

SGO 2027 Annual Meeting on Gynecologic Cancer

Society of Gynecologic Oncology (SGO)

19 Mar
SGO 2027

The Highlights of ASH 2027

American Society of Hematology (ASH)

19 Mar
ASH

The 42nd Annual EAU Congress

European Association of Urology (EAU)

19 Mar
42nd Annual EAU Congress

The Oncology Conference - ONCOLOGY 2026

Academia & Industria Forum

14 Sep
Oncology Conference

Immune-oncology
Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

CRISPR in Cancer Immunotherapy and Precision Oncology

Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Gastrointestinal-Oncology
GI Oncology

10 Must-Read Posts In GI Oncology This Week

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

EvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors

FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer

ctDNA in Gastrointestinal Cancers: What the Evidence Shows

DESTINY-PanTumor02: T-DXd in HER2-Expressing Biliary Tract or Pancreatic Cancers

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
LMD

Radiotherapy in Breast Cancer LMD: Critical Survival Uncertainty

After T-DXd: Why Switching ADC Targets May Not Be Enough

HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer

Patient-Reported GI Toxicity Reveals Hidden Burden With Neratinib Plus T-DM1

Tumor-Derived Extracellular Vesicles Reveal Hidden MBC Risk

HORIZON-Breast01: Trastuzumab Rezetecan Delivers 30.6-Month PFS

SUPREMO: Chest Wall Radiotherapy Has Limited 5-Year QOL Impact

Lung-Oncology
TP53

TP53-Mutated EGFR NSCLC: Powerful PFS Gain With Combination Therapy

Targeted Therapy Resistance in NSCLC: Critical Next Steps

SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

EGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker

Lung Cancer in Nonsmoking Individuals: A Distinct Clinical Profile

TREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
hematologic malignancies epidemiology

Hematologic Malignancies: Therapeutic Success Amid Epidemiological Failure

Hairy Cell Leukemia (HCL): A Rare Leukemia Treated Well, but Rarely Eradicated

Extramedullary Disease in Multiple Myeloma (EMD): Progress in the Immunotherapy Era

Access to TCRTs in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives

Autologous Stem Cell Transplantation (ASCT) for HIV-Associated Lymphoma: Latest Evidence

BTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives

Systemic Mastocytosis: A Hematologic Neoplasm Often Mistaken for Allergy and Other Conditions

Radiotherapy
DBCG Skagen Trial 1

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

IMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases

Shorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer

Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer

OncoDaily TV
Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

Not To Miss
VIRO

VIRO 2026 Brings Global Voices Together in Renal Oncology

Novo Nordisk and Amazon Web Services Partner to Accelerate Drug Discovery Through AI

Bristol Myers Squibb to Invest $2.3 Billion in New Houston Manufacturing Campus

ESO College Council Elections Announced for 2027–2028

An Evening for Cure: Fundraising Gala to Support New Comprehensive Cancer Center in Ghana

Hunter Biden Opens Up About Joe Biden’s Stage 4 Prostate Cancer: “It’s Really Sad to Watch”

CReDO: Where Oncology Research Ideas Become Research Protocols

OncoGrants
Inova

Inova Hematology and Oncology Fellowship 2027

ONS Congress Scholarship

ONS Congress Scholarship 2027

MRF Breakthrough

MRF Breakthrough Consortium Pilot Translational Award 2026

Clinical Innovator Grant

CRI Clinical Innovator Grant 2026–2027

CRI

CRI Clinic and Laboratory Integration Program Grant 2026

CRI IGNITE Award

CRI IGNITE Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Shui Yen Soh

Shui Yen Soh

Oncologists Location Singapore, Singapore
Daniel Olson

Daniel Olson

Oncologists Location Chicago, USA
Hany Ariffin

Hany Ariffin

Oncologists Location Kuala Lumpur, Malaysia
Javier David Benítez

Javier David Benítez

Oncologists Location Elche, Spain
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya
Gilberto Lopes

Gilberto Lopes

Oncologists Location Miami, USA
Enrique Soto Perez de Celis

Enrique Soto Pérez de Celis

Oncologists Location Aurora, USA
Trinanjan Basu

Trinanjan Basu

Oncologists Location Mumbai, India

Oncology Drugs
BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

NVL-655: Mechanism, Dose, Administration, And Clinical Trials

Fianlimab: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries